Please Share:: 
India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��
Aurobindo Pharma receives USFDA approval for Galantamine tablets
Aurobindo Pharma received final approval from the USFDA to manufacture and market
Galantamine tablets (strengths of 4mg, 8mg and 12mg), generic version of Razadyne. The
product is used in the treatment of mild to moderate dementia of the Alzheimer's type. The
product has a market size of approximately US$41mn for the 12 months ending
September 2010, according to IMS, and will be launched shortly. The stock is currently
trading at 9.4x and 9.6x its FY2011E and FY2012E earnings, respectively. We maintain
Buy on the stock with a target price of `210.
India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��
Aurobindo Pharma receives USFDA approval for Galantamine tablets
Aurobindo Pharma received final approval from the USFDA to manufacture and market
Galantamine tablets (strengths of 4mg, 8mg and 12mg), generic version of Razadyne. The
product is used in the treatment of mild to moderate dementia of the Alzheimer's type. The
product has a market size of approximately US$41mn for the 12 months ending
September 2010, according to IMS, and will be launched shortly. The stock is currently
trading at 9.4x and 9.6x its FY2011E and FY2012E earnings, respectively. We maintain
Buy on the stock with a target price of `210.
No comments:
Post a Comment